SCHEMBL29853435

SCHEMBL29853435

O=c1c2cc(O)ccc2c2ccc(O)cc2n1C1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ PDE2A O00408 1/20 0.37
▸ ESR1 P03372 2/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAT2A P31153 1/20 0.35
▸ POLB P06746 2/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ESRRA P11474 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ PKM P14618 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ PIK3CA P42336 2/20 0.33
▸ MTOR P42345 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26768267 1.00 METAP2 (0.42) METAP2GAAPDE2AESR1ALDH1A1
SCHEMBL26767445 0.90 GAA (0.40) METAP2GAAESR1ALDH1A1MEN1
SCHEMBL26775767 0.89 CYP2C9 (0.41) METAP2GAAESR1ALDH1A1MEN1
SCHEMBL26767567 0.88 GAA (0.43) METAP2GAAALDH1A1MEN1KMT2A
SCHEMBL26775993 0.84 GAA (0.43) METAP2GAAESR1ALDH1A1MEN1
SCHEMBL26775994 0.84 GAA (0.41) METAP2GAAESR1ALDH1A1MEN1
SCHEMBL26767535 0.81 JAK1 (0.38) METAP2GAANPSR1MAPTPIK3CA
SCHEMBL26767457 0.74 MPI (0.46) METAP2ALDH1A1MEN1KMT2APOLB
SCHEMBL30629150 0.74 MPI (0.46) METAP2ALDH1A1MEN1KMT2APOLB
SCHEMBL26767565 0.73 POLB (0.36) METAP2GAAALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119947717-A Therapeutic use of urolithin derivatives 范徳利亚股份公司 2025-05-06 — — CN disclosed
EP-4284781-A1 UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF Vandria SA (CH) 2023-12-06 — — EP disclosed
CN-117015530-A Urolithin derivatives and methods of use thereof 范徳利亚股份公司 2023-11-07 — — CN disclosed
WO-2022162471-A1 UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF VANDRIA SA (CH) 2022-08-04 — — WO disclosed
Send feedback